TradingView
jhains2
Apr 24, 2018 7:07 PM

AKAO Rounding Bottom in Place Ahead of 6/25 FDA Meeting Date Long

NASDAQ:AKAO1D

Description

⋅
The FDA will consider AKAO's lead drug on June 25th.

The stock appears to have put in a solid bottom ahead of that meeting.
Chart PatternsBeyond Technical Analysis
More